신성욱 교수

Despite remarkable advancement in the surveillance and treatment of hepatocellular carcinoma (HCC) and the availability of novel curative options, a great proportion of HCC patients are still not eligible for curative treatment due to an advanced tumor stage or poor hepatic functional reserve. Therefore, there is a continuing need for effective palliative treatments. Although practiced widely, it has only recently been demonstrated that the use of transarterial chemoembolization (TACE) provides

Despite remarkable advancement in the surveillance and treatment of hepatocellular carcinoma (HCC) and the availability of novel curative options, a great proportion of HCC patients are still not eligible for curative treatment due to an advanced tumor stage or poor hepatic functional reserve. Therefore, there is a continuing need for effective palliative treatments. Although practiced widely, it has only recently been demonstrated that the use of transarterial chemoembolization (TACE) provides

BACKGROUND: Although uterine artery embolization (UAE) is a well-recognized alternative treatment for postpartum hemorrhage (PPH) with a high clinical efficacy, the reported success rate of UAE for PPH associated with placenta accreta (PA) is lower. Recently, with advances in techniques and expertise, a few studies have reported favorable results of UAE in controlling PPH in the setting of PA. PURPOSE: To evaluate the efficacy of UAE in the emergent management of intractable PPH associated with

After TACE of the inferior phrenic artery, a substantial portion of patients showed functional and anatomic evidence of diaphragmatic weakness.

BACKGROUND: Given that transarterial chemoembolization (TACE) is usually a repeated procedure for treatment of hepatocellular carcinoma (HCC), repeated radiologic response assessments rather than a single time point assessment may have different clinical implications through the repeated course of TACE. PURPOSE: To evaluate the efficacy of RECIST and mRECIST criteria as a survival predictor across early time points after repeated TACE of HCC. MATERIAL AND METHODS: Ninety-eight patients with inte

BACKGROUND: Although peripherally-inserted central catheter (PICC) insertion is commonly performed under fluoroscopic guidance, few reports have addressed performance and dosimetry when PICC is inserted under C-arm fluoroscopy. PURPOSE: To evaluate the risk factors of radiation dose in performing PICC insertion using flat panel detector-based mobile C-arm fluoroscopy and a conventional angiography machine. MATERIAL AND METHODS: Ninety-eight patients underwent the PICC procedure using conventiona

목적: 우측 내경 정맥을 통하여 피하 터널식 중심정맥도관을 삽입한 경우 시술로 인한 합병증과 장기추적 결과를 알아보고자 하였다. 대상과 방법: 2001년 6월에서 2002년 5월 사이에 우측 내경 정맥을 통해 Hickman 도관을 삽입한 654명, 670예를 대상으로 시술과 관련된 합병증을 조사하고 2002년 7월까지의 추적결과를 분석하였다. 결과: 670예 중 669예(99.9%)에서 성공적으로 삽입했고 시술과 관련된 초기 합병증은 8예(1.2%) (기흉 3예, 조기위치 변위 1예, 공기색전증 1예, 도관 손상 1예, 도관 꺾임 1예 및 기정맥에 삽입된 1예 등)였다. Hickman 도관의 삽입기간은 1-407일(평균 107.1일)이었다. 추적기간 중 416예에서 Hickman 도관을 제거하였고 이 중 치료의 종료에 의한 경우가 334예, 환자의 치료 거부나 치료약제의 변경 등으로 인한 경우가 16예, 도관 관련 합병증에 의한 경우가 53예, 기타 13예였다. 후기 합병증 53예(

GIH can be a useful method to assist RFA for subcapsular HCC with iodized oil retention in patients with failed artificial ascites due to perihepatic adhesion.